Literature DB >> 2677808

Renal effects of indomethacin in patients with systemic lupus erythematosus.

E J ter Borg1, P E de Jong, S Meijer, C G Kallenberg.   

Abstract

We evaluated the effect of indomethacin on renal function in a sodium-restricted state in control subjects and in patients with systemic lupus erythematosus (SLE) without major disease activity and with normal or only slightly impaired glomerular filtration rate (GFR). In the patients with SLE indomethacin 150 mg daily induced a fall in GFR of mean 15.8%, while effective renal plasma flow remained constant. Neither effective renal plasma flow, nor GFR changed significantly in the controls. One should be aware that nonsteroidal anti-inflammatory drugs (NSAID) may decrease GFR in SLE, also in patients without disease activity and with normal or only slightly impaired GFR. As effective renal plasma flow remained constant, it is suggested that the indomethacin-induced fall in GFR in SLE is caused by mesangial contraction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677808     DOI: 10.1159/000185751

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis.

Authors:  Jim C Oates; Perry V Halushka; Florence N Hutchison; Philip Ruiz; Gary S Gilkeson
Journal:  Am J Med Sci       Date:  2011-02       Impact factor: 2.378

2.  Renal haemodynamic characteristics in patients with lupus nephritis.

Authors:  M Nakano; M Ueno; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

Review 3.  Atherosclerosis in systemic lupus erythematosus.

Authors:  George Stojan; Michelle Petri
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

4.  Management of cardiovascular complications in systemic lupus erythematosus.

Authors:  Carly Skamra; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2010-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.